CE-499648-005 RYANODINE RECEPTOR-2 (RYR2) INHIBITION WITH DANTROLENE SUPPRESSES INDUCIBLE VT: RESULTS OF A RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH STRUCTURAL HEART DISEASE

IF 5.6 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart rhythm Pub Date : 2025-04-01 DOI:10.1016/j.hrthm.2025.03.081

Majd El-Harasis, Zachary Yoneda, Bibin Varghese, Diane Crawford, Dakota Grauherr, Lili Sun, Fei Ye, Kara Siegrist, Frederic Billings, Bjorn C. Knollmann, William G. Stevenson, Ben B. Shoemaker

引用次数: 0

查看原文本刊更多论文

丹曲lene抑制ryyanodine receptor-2 （ryr2）抑制可诱导vt：一项结构性心脏病患者随机对照试验的结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart rhythm 医学-心血管系统

CiteScore

10.50

自引率

5.50%

发文量

1465

审稿时长

24 days

期刊介绍： HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.